L
Standard BioTools Inc.
LAB · NASDAQ · Healthcare · 279M
Closing price
$0.69
+2.85% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.6×
Enterprise value / EBITDAEV/EBITDA
-2.0×
Free cash flow yieldFCF yield
-31.4%
Return on equityROE
-17.7%
Operating margin
-109.3%
Net debt / EBITDAbalance-sheet strength
1.0×
Interest coverage
-3588.7×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.